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Background: To determine the outcome of central retinal vein occlusion (CRVO) in pre-existing glaucoma and the
predisposing factors of developing neovascular glaucoma (NVG).
Methods: We retrospectively assessed a pre-existing glaucoma CRVO group and a non-glaucoma CRVO group to
elucidate the demographics, clinical course and ocular parameters of these two cohorts. Among the pre-existing
glaucoma cases, the predisposing factors for the development of NVG were monitored, including the retinal capillary
non-perfusion status, intraocular pressure (IOP) and best-corrected visual acuity (BCVA) at presentation.
Results: Of 642 CRVO patients reviewed in this 10-year cohort study, 60 (9.3%) had pre-existing glaucoma at a mean
follow-up of 30.8 months, including 28 (4.4%) primary open angle glaucoma (POAG), 27 (4.2%) primary angle closure
glaucoma (PACG), and 5 (0.8%) normal tension glaucoma (NTG) cases. Although the presence of glaucoma in the CRVO
eyes was not significantly associated with the risk of developing NVG, the incidence of developing NVG in pre-existing
glaucoma eyes was significantly higher in the group with IOP greater than 20 mmHg at CRVO presentation (P = 0.02,
Chi-square test) as well as in the ischemic CRVO group compared to the non-ischemic patients (P = 0.005, Fisher’s exact
test). Overall, 20% of pre-existing glaucoma patients needed glaucoma surgery after a CRVO event, including 11.7% of
patients who developed iris neovascularisation (INV) and 8.3% of patients who developed a high IOP without INV.
Conclusions: Both the retinal non-perfusion status and uncontrolled IOP contribute to NVG in patients with
pre-existing glaucoma after CRVO. Following CRVO, glaucoma surgery is necessary for pre-existing glaucoma cases
with intractable elevated IOP with or without INV.
Keywords: Neovascular glaucoma, Central retinal vein occlusion with pre-existing glaucoma, Retinal non-perfusion
status, Intraocular pressure, Predisposing factorsBackground
Central retinal vein occlusion (CRVO) is a common
retinal vascular disease that leads to visual impairment
in elderly patients. Previous studies from Western
countries have a high incidence of pre-existing primary
open angle glaucoma (POAG) in patients with CRVO
[1-3]. However, Asian populations differ from Western
populations in that the incidence of primary angle clos-
ure glaucoma (PACG) is much higher. The incidence of
different types of pre-existing glaucoma, intraocular* Correspondence: c571019@cgmh.org.tw
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unless otherwise stated.pressure (IOP) changes and optic neuropathy in CRVO
in the Asian population is still unclear.
One-third of non-ischemic CRVO may convert to
ischemic CRVO [4]. The major complication of ische-
mic CRVO is neovascular glaucoma (NVG) [4,5]. In
CRVO patients with pre-existing glaucoma who have
developed NVG, severe corneal oedema and recalci-
trant high IOP are typically difficult to manage. There-
fore, damage to the optic nerve is difficult to avoid, and
any residual vision may be threatened. Thus far, it is
still unknown whether pre-existing glaucoma plays a
role in the development of NVG in CRVO patients.
Regardless of treatment with intravitreal injection oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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ticosteroids, conventional panretinal photocoagulation
(PRP) can regress retina neovascularisation in CRVO [6].
Because there is a paucity of evidence on this condi-
tion, the aim of this cohort study was to determine the
profile of pre-existing glaucoma in CRVO in the East
Asian population. Additionally, the secondary aims
were to explore the predisposing factors and outcomes
for the development of NVG in CRVO patients with
pre-existing glaucoma.
Methods
This was a retrospective and comparative long-term
cohort study. Patients were enrolled from Jul 1999 to
Dec 2009. This study was performed in accordance with
the Helsinki Declaration of 1975 (1983 revision) and was
approved by the Institutional Review Board of the Chang
Gung Memorial Hospital, Linkuo, Taiwan. All patients
diagnosed with CRVO were identified and followed up
monthly within one year, and their clinical data were
recorded during a chart review.
Demographic characteristics, including gender, age,
systemic diseases, the onset of CRVO and preceding eye
history, were collected. The general ocular examination,
including the best-corrected visual acuity (BVCA), slit-lamp
biomicroscope examination, IOP at the first diagnosis
of CRVO, indirect ophthalmoscopy, fluorescein angi-
ography findings, or related surgery history, was docu-
mented in detail.
In this 10-year CRVO cohort study, the study group
was consisted of pre-existing glaucoma cases diagnosed
with increased IOP, an optic cup/disc ratio larger than
0.5, and glaucomatous visual field changes. NVG was
defined as neovascularisation of the iris with an IOP
increase ≥ 21 mmHg. Optic nerve damage progression
was defined as an increasing cup/disc ratio. The type of
primary glaucoma, gonioscopy findings, optic cup/disc
ratio and visual field data were also recorded. Newly
diagnosed participants with CRVO were classified as
the control group. We excluded patients who received
intravitreous injection of anti-VEGF medications or tri-
amcinolone acetonide during the follow-up period. As a
proceeding analysis, patients who underwent vitrectomy
to clear vitreous haemorrhages, patients who presented
with distinct iris neovascularisation or neovascular glau-
coma during the first visit or patients with significant
diabetic retinopathy observed at short-term follow up
(shorter than six months) were also precluded from this
study. During the follow-up period, details regarding the
procedures were also recorded for patients who under-
went panretinal photocoagulation (PRP) or filtration
surgery after CRVO.
Data were entered into Excel and were analysed using
SPSS software (Statistical Package for Social Sciences).The differences between the non-glaucoma and pre-
existing glaucoma groups were evaluated using a chi-
square test and a 2-sample t-test for categorical and
continuous variables, respectively. For the patients
with pre-existing glaucoma, the relationships between
the development of NVG and ocular parameters were
examined using the Fisher’s exact test or Wilcoxon
rank sum test. Furthermore, the visual and optic nerve
changes between the initial and final stages were
assessed using the Wilcoxon signed-rank test. In this
study, the Snellen visual acuity was converted to the
logarithm of the minimum angle of resolution (logMAR)
units for analysis. A p value of less than 0.05 was consid-
ered significant.
Results
Overall, 642 patients with CRVO were reviewed in this
10-year cohort study. There were 60 eyes from 60
patients who had a history of pre-existing glaucoma
before the onset of CRVO. The incidence of pre-existing
glaucoma in CRVO was 60/642 (9.3%). Regarding the
various types of pre-existing glaucomas, there were 28
primary open angle glaucoma (POAG) cases, 27 primary
angle closure glaucoma (PACG) cases and 5 normal
tension glaucoma (NTG) cases in this study. A total of
321 patients were excluded from this study due to
vitrectomy surgery or intravitreal injections of triam-
cinolone acetonide or anti-VEGF. To compare the
characteristics, 60 pre-existing glaucoma cases were
categorised as the study group, and 261 non-glaucoma
cases were categorised as the control group.
The demographics, clinical characteristics and baseline
ocular parameters are listed in Table 1. In the pre-
existing glaucoma group, the age of CRVO onset was
significantly older than the control group (57.3 vs.
67.2 years, p<0.001). The prevalence of males was much
higher than that of females in both groups. When com-
paring the ocular parameters, the cup/disc (C/D) ratio
was substantially larger in the study group compared to
the control group. According to the FAG finding, the
proportion of ischemic type CRVO was higher in the
pre-existing glaucoma group than in the control group
(39.8% VS 45%), although not significantly (p=0.46).
Moreover, during CRVO diagnosis, approximately one
half (48.3%) of the pre-existing glaucoma participants
exhibited a higher increase in the IOP compared to the
control group (21.7±9.2 vs. 13.9±4.8 mmHg, p<0.001).
However, the vision (BVCA) of both groups at the time
of diagnosis was similar. There was no significant differ-
ence in the proportion of ischemic type CRVO between
the two groups (Table 1). In general, 20.3% (53/261) of
the non-pre-existing glaucoma cases and 31.7% (19/60)
of the pre-existing glaucoma cases developed NVG.
(p=0.06) Furthermore, the incidence of NVG occurred
Table 1 Demographic and ocular characteristics of pre-existing glaucoma in central retinal vein occlusion (CRVO)
Non-glaucoma Pre-existing glaucoma p value†
Case number 261 60
Gender (female:male) 102: 159 25: 35 0.712
Age (mean±SD) 57.3±17.5 67.2±14.9 <0.001
Systemic disease
DM 71 (27.2%) 14 (23.3%) 0.540
HTN 131 (50.2%) 29 (48.3%) 0.795
CRVO onset (months) (mean±SD) 1.6±3.8 1.7±3.6 0.832
Perfusion status 0.464
Non-ischemic 157 (60.2%) 33 (55%)
Ischemic 104 (39.8%) 27 (45% )
C/D ratio (mean±SD) 0.42±0.09 0.72±0.16 <0.001
IOP at presentation (mmHg) (mean±SD) 13.9±4.8 21.7±9.2 <0.001
BCVA (logMAR) (mean±SD) 1.46±0.85 1.69±0.84 0.053
PRP during follow up 107 (41%) 22 (36.7%) 0.537
NVG during follow up 53 (20.3%) 19(31.7%) 0.057
Abbreviations: BCVA best-corrected visual acuity, C/D cup-to-disc, DM diabetes mellitus, HTN hypertension, IOP intraocular pressure, log MAR logarithm of the
minimal angle of resolution, and SD standard deviation.
†p values were calculated using the chi-square test and 2-sample t-test for categorical and continuous variables, respectively.
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cases in the pre-existing glaucoma group and 81.18%
(43/53) of cases in the control group (p= 0.05).
It is well known that the major complication after the
onset of CRVO is the development of NVG, and IOP is
typically intractable to medical treatment. To further
identify the predisposing factors among the ocular
parameters that contribute to the development of NVG
in the study group, at the first visit, the IOP, C/D, and
retinal nonperfusion status were obtained (Table 2). In
the univariate analysis of the development of NVG, there
was a significant difference in the mean IOP at the time
of presentation between NVG within 0.5 yr and non-
NVG within 0.5 yr (29.2±10.1 vs. 19.8±8.29, P=0.007,
Wilcoxon rank sum test). Additionally, when the IOP
was dichotomised as >20 or≦20 mmHg, 10 out of 32
(31.3%) patients with IOP >20 mmHg and 2 out of 28
(7.1%) with IOP ≦20 mmHg developed NVG withinTable 2 NVG within 0.5 yr after CRVO in pre-existing glaucom
NVG
within




Mean IOP at presentation (mmHg) (mean±SD) 29.2±
IOP > 20 mmHg at presentation 10
IOP ≦ 20 mmHg at presentation 2
*Fisher’s exact test; **Wilcoxon rank sum test; and ***Chi-square test.0.5 yr, respectively (Chi-square test, P=0.020). Consider-
ing another fundamental parameter in the pre-existing
glaucoma group that is associated with NVG develop-
ment, a majority (93.3%) of the patients had moderate to
severe cupping upon the diagnosis of CRVO. The aver-
age C/D upon the presentation of CRVO was 0.72 in the
study group. A high incidence of a large C/D ratio was
found as 38.3% of the patients in the study group had
moderate cupping (0.5≦C/D<0.8) and 55% had severe
cupping (≧0.8). For pre-existing glaucoma patients, there
was a marginal significant difference in the C/D ratio
between NVG within 0.5 yr and non-NVG within 0.5 yr
[0.78±0.17, (range: 0.4-0.9) vs. 0.70±0.16, median 0.75
(range: 0.4-0.9) using the Wilcoxon rank sum test
(P=0.053)]. During the study period of 30.8 months, C/D
increased to subtotal cupping in 37 out of 60 (61.7%)
cases, indicating that the RNFL continued to thin, which
is a serious consequence after retinal haemorrhage isa
0.5 yr
Non-NVG
within 0.5yr p value
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was significantly higher in the pre-existing glaucoma and
control group patients with ischemic type CRVO com-
pared to non-ischemic type CRVO.(p=0.005 and p<0.001,
Fisher’s exact test).
Accordingly, panretinal photocoagulation (PRP) was
suggested in cases where neovascularisation of the iris
occurred at follow-up. Nevertheless, there were 2 PACG
cases with an initially normal IOP, which spiked after
PRP was performed, and IOP stabilised with additional
medication. Seventy-five percent of pre-existing glau-
coma patients were regularly using anti-glaucoma agents
before the first CRVO event. Among 27 pre-existing
PACG patients, 9 patients had received laser iridotomy.
Surgical interventions for NVG patients, including fil-
tration surgery and transscleral cyclophotocoagulation,
are summarised in Table 3. For patients with end stage
glaucoma and poor vision, the type of surgery per-
formed (trabeculectomy with mitomycin C or transscle-
ral cyclophotocoagulation) depended on the physician’s
preference and patients’ agreement. An intractable IOP
increase without INV was treated with trabeculectomy
with or without an antimetabolite agent if useful vision
was still present. In this retrospective cohort study, 12
cases (20%) needed surgical intervention to control IOP
during the long-term follow up. The two major causes
of surgery were uncontrolled IOP in cases that devel-
oped NVG (11.7%) and intractable IOP without iris NV
(8.3%). It is worth noting that there were some pre-
existing glaucoma cases that flared up with high IOP
without INV, and medical intervention was not suffi-
cient thereafter.
Due to the retrospective nature of this study, the exact
time point of conversion from the non-ischemic to
ischemic type is difficult to detect. For example, a case
of NTG with a BCVA of 0.6 with non-ischemic CRVO
at presentation converted to ischemic CRVO that was
subsequently complicated with NVG. This patient then
hesitated PRP, and vision decreased to light sense nega-
tive. According to the records, 5 out of 33 non-ischemic
cases in the pre-existing glaucoma group (15.1%) devel-
oped NVG, and ischemic development was noted as
possible for future development during the study period.Table 3 The management of various types of pre-existing gla
POAG
Case number 28
Prior use of antiglaucomaagents 26 (92.9%)
Mean deviation (dB) -15.07
Trabe/TSCP for NVG 1/3 (14.3%)
Trabe for elevated IOP (w/o INV) 2 (7.1%)
Abbreviations: PACG primary angle closure glaucoma, POAG primary open angle gla
TSCP transscleralcyclophotocoagulation, and w/o INV without iris neovascularisationIn general, vision did not significantly improve after con-
ventional glaucoma management up to the 31-month
follow-up. In patients with pre-existing glaucoma, vision
deteriorated from an initial BCVA log MAR 1.69 (Snellen
0.02) to a final BCVA log MAR1.84 (Snellen 0.014).
Because there are three types of pre-existing glaucoma, we
analysed the visual outcome based on the mean BCVA
and cup disc ratio change (Table 4). As indicated above
and in Table 1, the C/D ratio for pre-existing glaucoma
cases at CRVO presentation was larger than the control
group (0.72 vs. 0.42). When the initial and final ratios were
compared, the C/D ratio significantly increased in the
overall, POAG, and PACG subgroups. This result
demonstrates that the retinal nerve fibre layer defect
continued to progress after CRVO, which may be asso-
ciated with further deterioration of vision for these
pre-existing glaucoma cases.
Discussion
Glaucoma is one of the known risk factors for CRVO
[1,2,7,8]. A major complication of CRVO is the develop-
ment of NVG, which can lead to severe visual impair-
ment. Pre-existing glaucoma is seldom included in
CRVO studies in Asian populations where the preva-
lence of PACG is higher than in the Western countries.
Ethnicity may play an important role when evaluating
ocular diseases related to glaucoma.
In this 10-year cohort study, the incidence of pre-
existing glaucoma in CRVO was similar to previous
studies [7,9]. Recently, Michaelides and Foster also sug-
gested that angle-closure may be associated with retinal
vein occlusions in retrospective case series with diverse
ethnicity [10]. In contrast, Hayreh et al. concluded that
compartment syndrome contradicts the concept of play-
ing a role in RVO [11]. In this study, it is notable that
the incidence of PACG was approximately equal to
POAG in CRVO. Regarding demographic and ocular
parameters, CRVO was more prevalent in the elderly
and middle to late stage glaucoma cases with large
cupping. Although we do not have exfoliative glaucoma
cases in our study, Prata et al. manifested that retinal
vascular occlusion in patients with exfoliation syndrome
occurs most frequently in the affected or more severelyucoma in central retinal vein occlusion (CRVO)
PACG NTG Overall incidence
27 5
16 (26.7%) 3 (60%) 75%
-13.02 -16.21 -14.24
1/2 (11.1%) 0 11.7%
3 (11.1%) 0 8.3%
ucoma, PRP pan-retinal photocoagulation, Trabe trabeculectomy,
.
Table 4 Visual and optic nerve changesin various pre-existing glaucoma types
POAG PACG NTG Overall
Case number 28 27 5
IOP at presentation (mmHg) 24.3±10.0 19.7±7.4 18.6±11.3 21.7±9.2
Baseline BCVA (Snellen) 0.027 0.015 0.023 0.02
Final BCVA (Snellen) 0.018 0.013 0.005 0.014
Cup-to-disc ratio
Initial (mean±SD) 0.69±0.17 0.72±0.16 0.88±0.04 0.72±0.16
Final (mean±SD) 0.75±0.16 0.77±0.14 0.88±0.04 0.77±0.15
p value† 0.01 0.036 0.001
Follow-up (months) (mean±SD) 30.1±26.9 32.3±32.8 25.8±22.7 30.8±29.1
Abbreviations: BCVA best-corrected visual acuity, NVG neovascular glaucoma, PACG primary angle closure glaucoma, POAG primary open angle glaucoma, and SD
standard deviation.
†Changes betweenthe initial and final cup-to-disc ratio were examined using the Wilcoxon signed-rank test.
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sus that large cupping in glaucoma patients is vulnerable
to CRVO [3,12]. Moreover, the incidence of the ischemic
CRVO type in pre-existing glaucoma was similar to that
in the non-glaucoma population.
Beaumont et al. found that retinal venous occlusion at
the optic cup has a higher IOP, C/D ratio and prevalence
of POAG [3]. In contrast, Hayreh et al.compared CRVO
patients and found that even without glaucoma medica-
tion, patients with pre-existing glaucoma had a lower
IOP in the lesion eye compared to patients without pre-
existing glaucoma [13,14]. Cappin et al. found that the
IOP was 4 mmHg lower in the CRVO eye compared to
the other eye in glaucoma patients. By iris angiography,
they also found that the vessel of the iris was relatively
dilated in CRVO eyes [15]. However, in the Taiwanese
population, 46.7% and 45% of patients in the pre-existing
glaucoma group were POAG and PACG, respectively. The
IOP at CRVO presentation was higher in the pre-existing
glaucoma group (mean: 21.7 mmHg) compared to the
non-pre-existing glaucoma group (13.9 mmHg). Because
the mean diagnosed time was approximately 1.5 months
in this study, it is unknown whether the IOP increase
occurred before or after CRVO. The exact mechanism of
IOP change after CRVO in different types of glaucoma
requires further evaluation.
According to an evidence-based study on the natural
course of CRVO, the proportion of non-ischemic cases
that converted to ischemic cases was as high as 30% in
three years [4]. The ischemic type CRVO can lead to
NVG in 20% of patients [4]. In our study, for ischemic
CRVO, there were more cases with NVG within 6 months
in the pre-existing glaucoma group than the control
group, but the number of cases was similar after long-
term follow up. It is important to understand the other
predisposing factors that contribute to the development of
NVG in cases with primary glaucoma. We found that
in patients with pre-existing glaucoma, the formation ofNVG within 0.5 yr was significantly, positively correlated
with IOP at presentation and marginally correlated with
the C/D ratio at presentation. Due to the retrospective
nature of this study, it is difficult to determine the exact
IOP changes at the onset of CRVO. However, higher IOP
or poor IOP control could theoretically compromise blood
perfusion and increase the risk of neovascularisation of
the iris. Therefore, it is important to periodically measure
the IOP and control IOP after a CRVO event.
There was a similar incidence of the conventional man-
agement of PRP among the two groups, which suggests
that pre-existing glaucoma is not prone to rubeosis iridis.
According to the results of this study, the incidence of
neovascular glaucoma with increased IOP was lower than
the incidence of PRP performed for cases of rubeosis iri-
dis. Although PRP was effective in eliminating ocular neo-
vascularisation in CRVO in this study, Hayreh et al.
revealed marked peripheral visual field loss after laser
treatment [16]. One of the drawbacks of this retrospective
study was the absence of visual field data collected after a
CRVO event from; as a result, we could not conclude
anything about the change in the visual field. Furthermore,
a relatively high proportion (approximately 20%) of pre-
existing glaucoma patients underwent glaucoma surgery
after a CRVO event. This is the first study to address the
consequence of two major causes of glaucoma surgery,
NVG or persistent elevated IOP without ocular neovascu-
larisation. The pathogenesis of intractable increased IOP
without iris neovascularisation after CRVO is not clear. In
previous reports, the levels of vascular endothelial growth
factor were increased in the aqueous humour of glaucoma
cases [17]. After a CRVO event, reduced blood flow in
the retinal capillaries leads to hypoxia, upregulation and
release of VEGF and ocular neovascularisation. Intractable
IOP may be secondary to hypoxic and inflammatory
changes after CRVO, all of which aggregated in the
pre-existing glaucoma cases even though ocular neovascu-
larisation did not develop.
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diabetic retinopathy and performance of PRP do not
correlate with progressive enlargement of cupping [18].
In contrast, this study found that the ischemic change of
the retina after CRVO in pre-existing POAG and PACG
revealed a retinal nerve fibre layer defect, which pro-
gressed throughout the study period. Although with the
limitation of the study that different clinicians observed
the cupping, this study illustrates the change in the
neuroretinal rim in CRVO with pre-existing glaucoma
and may partially explain the reason for progressive
deteriorated vision in these patients. Generally speaking,
vision progressively deteriorated during the long-term
follow up in this cohort study.
Conclusions
The distribution of pre-existing glaucoma in CRVO in the
Taiwanese population is different from Western countries.
Identifying the profile of pre-existing glaucoma in CRVO is
fundamental to further identify effective management
strategies. Both the retinal non-perfusion status and
uncontrolled IOP contribute to NVG in patients with
pre-existing glaucoma after CRVO. Physicians should
be aware of the increased IOP after CRVO during
follow-up, and glaucoma surgery is necessary for pre-
existing glaucoma cases with intractable elevated IOP
with or without INV. For such underlying glaucoma
diseases associated with glaucomatous optic nerve atro-
phy, prompt beneficial therapy to prevent complica-
tions and preserve vision requires further study.
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